Cagrilintide 10mg Peptides
Precision-driven research starts with uncompromising materials you can trust.
The Primavora Cagrilintide lyophilized peptide vial is designed for exacting laboratory workflows, delivering 10mg total content per vial. Presented as a clean, stable lyophilized cake, this research-grade amylin analog supports careful handling, controlled preparation, and consistent performance across method development and exploratory studies. The unflavored, neutral format integrates smoothly into validated lab protocols where purity and reproducibility are essential.
- Each vial contains 10mg of Cagrilintide, a long-acting amylin receptor agonist investigated in preclinical models for its effects on satiety signaling, gastric emptying, and energy balance, enabling rigorous inquiry in metabolic research settings.
The lyophilized presentation aids stability and simplifies precise reconstitution volumes, helping researchers achieve clear, repeatable conditions vial to vial. The solid cake format supports accurate aliquoting, minimal waste, and efficient inventory management. With a clean composition suitable for analytical characterization, the material is prepared to align with modern lab expectations for traceability, clarity, and consistency.
Primavora emphasizes disciplined quality from sourcing through fulfillment. Each lot is produced in the USA under rigorous quality controls with analytical verification, including HPLC purity assessment and mass confirmation, and is supported by a lot-specific Certificate of Analysis for transparent documentation. Vials are filled and sealed in a controlled environment with careful chain-of-custody practices to help safeguard integrity through transit and storage. Our approach reflects a commitment to dependable research materials that meet the standards of serious investigation.
Ingredients: Cagrilintide (peptide). No additional active ingredients.
For laboratory research use only. Not for human consumption, medical use, or veterinary use. Handle using appropriate laboratory procedures and protective equipment. Store securely, protected from light and moisture, and use within validated protocols. By focusing on purity, consistency, and lot-level transparency, Primavora provides researchers with a reliable foundation for precise, repeatable work.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog used in metabolic research. It belongs to the incretin-adjacent appetite-regulation space rather than the classic growth-hormone or repair-peptide category. On a product page, the accurate framing is that it is a research compound studied for metabolic signaling, not an approved consumer-use peptide.
What is Cagrilintide typically studied for?
Cagrilintide is usually studied in relation to appetite regulation, satiety signaling, gastric-emptying effects, and body-weight change in experimental models. It is also often discussed alongside GLP-1-based research because both areas intersect around energy intake and metabolic control.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
